SCHEMBL2760751

SCHEMBL2760751

CCC(O)c1cc(C(=O)O)cc(-c2ccc(C)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.49
RXRA P19793 5/20 0.46
RXRB P28702 5/20 0.46
FABP1 P07148 1/20 0.44
P2RY14 Q15391 1/20 0.44
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CTRC Q99895 1/20 0.42
ADRB3 P13945 1/20 0.40
RXRG P48443 1/20 0.40
MCL1 Q07820 1/20 0.40
LMNA P02545 1/20 0.40
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
SRD5A2 P31213 1/20 0.39
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
MAP4K4 O95819 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16418271 0.88 DHODH (0.49) DHODHRXRARXRBFABP1P2RY14
SCHEMBL2760718 0.85 DHODH (0.46) DHODHRXRARXRBFABP1P2RY14
SCHEMBL2760860 0.83 DHODH (0.52) DHODHRXRARXRBFABP1P2RY14
SCHEMBL1495693 0.79 DHODH (0.52) DHODHRXRARXRBFABP1P2RY14
SCHEMBL2760813 0.79 DHODH (0.41) DHODHRXRARXRBFABP1P2RY14
SCHEMBL16196117 0.79 DHODH (0.70) DHODHRXRARXRBFABP1P2RY14
SCHEMBL1495453 0.79 DHODH (0.70) DHODHRXRARXRBFABP1P2RY14
SCHEMBL16418270 0.79 GAA (0.51) DHODHRXRARXRBALDH1A1ADRB3
SCHEMBL3068080 0.78 DHODH (0.48) DHODHRXRARXRBFABP1P2RY14
SCHEMBL2778738 0.78 P2RX3 (0.47) DHODHALDH1A1LMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150266822-A1 Amide Compounds, Compositions And Uses Thereof RENOVIS, INC. 2015-09-24 US claimed
CN-104058999-A Amide Compounds, Compositions And Uses Thereof RENOVIS INC 2014-09-24 CN claimed
EP-2262766-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF Renovis, Inc. (US) 2010-12-22 EP claimed
WO-2009110985-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF RENOVIS, INC. (US) 2009-09-11 WO claimed
US-20150266822-A1 Amide Compounds, Compositions And Uses Thereof RENOVIS, INC. 2015-09-24 US disclosed
US-8946439-B2 Amide compounds, compositions and uses thereof EVOTEC AG (DE) 2015-02-03 US disclosed
CN-104058999-A Amide Compounds, Compositions And Uses Thereof RENOVIS INC 2014-09-24 CN disclosed
CN-104016907-A Amide compounds, compositions and uses thereof RENOVIS INC 2014-09-03 CN disclosed
EP-2262766-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF Renovis, Inc. (US) 2010-12-22 EP disclosed
WO-2009110985-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF RENOVIS, INC. (US) 2009-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266822-A1 Amide Compounds, Compositions And Uses Thereof IL1B, ADORA2B, AVPR1B DHODH 3626/4885RXRA 380/4885RXRB 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.